Eikon Therapeutics

A series of dice with a bag on them illustrating cost cuts

Eikon blames US cuts for 15% staff reduction

Only three months after banking a $350 million series D, Eikon Therapeutics is blaming government cuts for its decision to lay off 15% of its employees.

James Waldron May 22, 2025 7:55am

Eikon remains in megaround mode with $350M series D

Feb 26, 2025 9:40am

Pfizer replaces retiring CSO with cancer chief—Chutes & Ladders

Nov 22, 2024 8:30am

Eikon, Dewpoint investors raise new $630 million fund

Jan 29, 2024 9:39am

Eikon cuts staff to 'become more efficient,' CEO says

Oct 7, 2023 6:36pm

Eikon builds out clinical development team—Chutes & Ladders

Jun 2, 2023 9:30am